- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02627040
Intertrochanteric Femoral Fracture Fixation Trial
A Prospective Randomized Trial of Intertrochanteric Femoral Fractures Treated With a Single Screw Versus a Two-integrated Screw Cephalo-medullary Nail.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary Hypotheses:
Patients who maintain their initial fracture reduction and subsequent position over time with minimal femoral neck shortening and varus will demonstrate significantly improved functional abilities, including gait and abductor function.
Secondary Objective:
- Whether radiographic differences in femoral neck shortening and varus collapse translate into a worse functional outcome to the patient.
- Whether there are differences in mortality between treatments
- Whether there is a time frame follow up after which there is no difference in outcomes.
- Evaluate the device used for fracture stabilization as a potentially contributing factor for maintenance of normal or near-normal abductor function and gait.
Primary Outcome:
The primary outcome will be functional abilities at 3, 6 and 12 months after injury. The following measures of functional ability will be utilized:
Methods:
This is a prospective, randomized non-blinded study. Patients will be identified as they present to the orthopaedic trauma service of Tampa General Hospital with a qualifying injury to determine their interest in participating in the study. Written informed consent will be obtained prior to initiation of any study procedures.
Group A will undergo cephalomedullary nail-based single screw intertrochanteric hip fracture fixation device (Gamma 3 nail). Group B will receive the integrated dual screw intertrochanteric hip fracture fixation device (Intertan nail). Patient outcomes will be analyzed using intention to treat principles. Following randomization assignment, surgeons will all follow the identical described surgical technique, with the only variable being the implant used. Post-operative immobilization and time to weight bearing and rehabilitation protocols will be again identical for all patients regardless of fixation technique.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Brandon, Florida, United States, 33511
- Brandon Regional Hospital
-
Tampa, Florida, United States, 33606
- Tampa General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Patients surgically treated for an intertrochanteric femur fracture at Tampa General Hospital.
- Skeletally mature patients over the age of 60; both genders.
- Community ambulators.
Exclusion Criteria:
- Patients with ipsilateral lower extremity injury
- Patients under age 60
- Co-existent, severe knee or back problems
- Muscle contracture around the knee or hip joint
- Individuals who have had TKA within 6 months
- Body mass index (BMI; kg/m2) >40
- Suspicious of pathologic fracture (tumor in origin)
- Pre-op mobility: Non ambulatory; ambulatory indoors with living support
- Cognitive impairment or dementia
- Prisoners or impending incarceration
- Homeless or no stable address.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: InterTan Intertrochanteric Nail
'Surgical fixation' of intertrochanteric fracture with a cephalomedullary nail with an InterTan device (two-integrated screws)
|
Cephalomedullary fixation of intertrochanteric fracture with an InterTan Intertrochanteric Nail
|
Active Comparator: Gamma 3 Intertrochanteric Nail
'Surgical fixation' of intertrochanteric fracture with a cephalomedullary nail and Gamma 3 locking nail (single screw)
|
Cephalomedullary fixation of intertrochanteric fracture with an Gamma 3 Intertrochanteric Nail
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hip Function
Time Frame: 6 months post-operatively
|
Hip Function measured with Harris Hip Score.
|
6 months post-operatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional outcome
Time Frame: 6 months post-operatively
|
Functional outcome will be measured using the following outcome measurement: Gait analysis using MiniSun's IDEEA® LifeGait System, a portable device for assessment of functional gait outcomes.
|
6 months post-operatively
|
Walking ability
Time Frame: 3 months post-operatively
|
Subjects will wear a pedometer applied in the immediate post-operative period, and will continue to wear it for 3 months.
Total walking steps will be measured.
|
3 months post-operatively
|
Hip range of motion
Time Frame: 6 months post-operatively
|
Range of motion of hip measured with Harris Hip Score.
|
6 months post-operatively
|
Hip Pain
Time Frame: 6 months post-operatively
|
Pain measured with Harris Hip Score.
|
6 months post-operatively
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hassan R Mir, MD, MBA, Florida Orthopaedic Institute
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00023144
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Fracture
-
University Health Network, TorontoNot yet recruitingSurgery | Hip-fracture
-
Lund UniversityMalmo Municipality, SwedenRecruiting
-
Hvidovre University HospitalCompleted
-
Michal Roll PhD,MBATel-Aviv Sourasky Medical CenterUnknown
-
The University of Hong KongRecruiting
-
Mayo ClinicCompletedPertrochanteric Hip FractureUnited States
-
Eurofarma Laboratorios S.A.TerminatedHip Fracture SurgeryBrazil
-
National Institute of Arthritis and Musculoskeletal...Completed
-
AO Clinical Investigation and Publishing DocumentationCompletedHip Fractures | Closed Fracture of HipIsrael, Austria, Switzerland, Germany, Belgium, Norway
Clinical Trials on InterTan Intertrochanteric Nail
-
Lawson Health Research InstituteOrthopaedic Research FoundationCompleted
-
Rabin Medical CenterUnknownClosed Comminuted Oblique Intertrochanteric Fracture of Neck of Right Femur | Closed Comminuted Oblique Intertrochanteric Fracture of Neck of Left FemurIsrael
-
Prisma Health-UpstateArthrex, Inc.Enrolling by invitationIntertrochanteric FracturesUnited States
-
AO Clinical Investigation and Publishing DocumentationCompletedReverse Oblique Intertrochanteric Fractures | Reverse Oblique Subtrochanteric FracturesAustralia, Switzerland
-
Haukeland University HospitalCompletedTrochanteric and Subtrochanteric Hip Fractures | Treatment With a New Nail or a Sliding Hip ScrewNorway
-
Paul E. MatuszewskiNot yet recruiting
-
Smith & Nephew Medical (Shanghai) LtdWithdrawnFemoral Fractures | Hip FracturesChina
-
Assiut UniversityRecruiting
-
Taipei Medical University WanFang HospitalUnknown